Related references
Note: Only part of the references are listed.Combination of the Hematopoietic Cell Transplantation Comorbidity Index and the European Group for Blood and Marrow Transplantation Score Allows a Better Stratification of High-Risk Patients Undergoing Reduced-Toxicity Allogeneic Hematopoietic Cell Transplantation
Pere Barba et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2014)
CMV serostatus still has an important prognostic impact in de novo acute leukemia patients after allogeneic stem cell transplantation: a report from the Acute Leukemia Working Party of EBMT
Martin Schmidt-Hieber et al.
BLOOD (2013)
How I assess comorbidities before hematopoietic cell transplantation
Mohamed L. Sorror
BLOOD (2013)
Hematopoietic SCT in Europe: data and trends in 2011
J. R. Passweg et al.
BONE MARROW TRANSPLANTATION (2013)
A competing risks analysis should report results on all cause-specific hazards and cumulative incidence functions
Aurelien Latouche et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2013)
Estimating and comparing time-dependent areas under receiver operating characteristic curves for censored event times with competing risks
Paul Blanche et al.
STATISTICS IN MEDICINE (2013)
Acute myeloid leukemia in the real world: why population-based registries are needed
Gunnar Juliusson et al.
BLOOD (2012)
Role of HCT-comorbidity index, age and disease status at transplantation in predicting survival and non-relapse mortality in patients with myelodysplasia and leukemia undergoing reduced-intensity-conditioning hemopoeitic progenitor cell transplantation
S. W. Bokhari et al.
BONE MARROW TRANSPLANTATION (2012)
The European LeukemiaNet AML Working Party consensus statement on allogeneic HSCT for patients with AML in remission: an integrated-risk adapted approach
Jan J. Cornelissen et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2012)
Retrospective analysis of common scoring systems and outcome in patients older than 60 years treated with reduced-intensity conditioning regimen and alloSCT
L. Castagna et al.
BONE MARROW TRANSPLANTATION (2011)
Comparison of Two Pretransplant Predictive Models and a Flexible HCT-CI Using Different Cut off Points to Determine Low-, Intermediate-, and High-Risk Groups: The Flexible HCT-CI Is the Best Predictor of NRM and OS in a Population of Patients Undergoing allo-RIC
Pere Barba et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2010)
A modified comorbidity index for hematopoietic cell transplantation
T. E. DeFor et al.
BONE MARROW TRANSPLANTATION (2010)
A modified EBMT risk score and the hematopoietic cell transplantation-specific comorbidity index for pre-transplant risk assessment in adult acute lymphoblastic leukemia
Theis H. Terwey et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2010)
Assessment of the Hematopoietic Cell Transplantation Comorbidity Index in Non-Hodgkin Lymphoma Patients Receiving Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation
Seth M. Pollack et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2009)
Risk Score for Outcome After Allogeneic Hematopoietic Stem Cell Transplantation A Retrospective Analysis
Alois Gratwohl et al.
CANCER (2009)
Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia in First Complete Remission Systematic Review and Meta-analysis of Prospective Clinical Trials
John Koreth et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
The hematopoietic cell transplantation comorbidity index (HCT-CI) predicts clinical outcomes in lymphoma and myeloma patients after reduced-intensity or non-myeloablative allogeneic stem cell transplantation
L. Farina et al.
LEUKEMIA (2009)
Hematopoietic cell transplantation-specific comorbidity index as an outcome predictor for patients with acute myeloid leukemia in first remission: combined FHCRC and MDACC experiences
Mohamed L. Sorror et al.
BLOOD (2007)
High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation
Stephanie J. Lee et al.
BLOOD (2007)
Comorbidity and disease status-based risk stratification of outcomes among patients with acute myeloid leukemia or myelodysplasia receiving allogeneic hematopoietic cell transplantation
Mohamed L. Sorror et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Results of a HOVON/SAKK donor versus no-donor analysis of myeloablative HLA-identical sibling stem cell transplantation in first remission acute myeloid leukemia in young and middle-aged adults: benefits for whom?
Jan J. Cornelissen et al.
BLOOD (2007)
A risk score for mortality after allogeneic hematopoietic cell transplantation
T Parimon et al.
ANNALS OF INTERNAL MEDICINE (2006)
Outcomes of reduced-intensity transplantation for chronic myeloid leukemia: an analysis of prognostic factors from the Chronic Leukemia Working Party of the EBMT
C Crawley et al.
BLOOD (2005)
Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT
ML Sorror et al.
BLOOD (2005)
Efficacy of allogeneic hematopoietic stem cell transplantation depends on cytogenetic risk for acute myeloid leukemia in first disease remission - A metaanalysis
M Yanada et al.
CANCER (2005)
Comparison of lung function after myeloablative and 2 Gy of total body irradiation-based regimens for hematopoietic stem cell transplantation
JW Chien et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2005)
Internal and external validation of predictive models: A simulation study of bias and precision in small samples
EW Steyerberg et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2003)
Share Paper
